Results 191 to 200 of about 128,453 (260)
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
Aims The Black Triangle Scheme, introduced in 2018 in Australia, does not appear to have increased the quantity of adverse drug event (ADE) reports. This study evaluated healthcare professionals' (HCPs') and consumers' awareness of the scheme, its influence on intentions for future ADE reporting, and suggested improvements.
Eyob Alemayehu Gebreyohannes +7 more
wiley +1 more source
Binaural pitch fusion in cochlear implant users is broader and narrower with coherent and incoherent envelope modulation, respectively. [PDF]
Oh Y, Reiss L.
europepmc +1 more source
Leadless Pacing for Delayed Heart Block After Transcatheter Tricupid Valve Replacement. [PDF]
Geerlings AE +8 more
europepmc +1 more source
HPV prevention awareness, vaccination willingness, and vaccine-related perceptions among middle-school girls in three Arab countries: an exploratory online survey. [PDF]
Ibrahim FM +4 more
europepmc +1 more source
Beyond the Shortage: What Rural Medicine Still Gets Right. [PDF]
Burmeister JR, Rubino IJ.
europepmc +1 more source
Listeners do not tune in to more rewarding voices. [PDF]
Lim SJ, Zi L.
europepmc +1 more source

